Lucis
YC X25Paris, FR · Founded 2025 · 17 employees · Hiring · 9 known investors
Lucis provides personalized health monitoring and guidance by combining laboratory biomarker testing with educational insights and actionable recommendations. The platform helps individuals and healthcare providers identify health risks early through accredited laboratory tests across Europe, with results explained in accessible language.
Also known as Lucis (ex-Zero Health) · Zero Health · Lucis
Founders & leadership· Y Combinator alumni (X25)
Lucis was founded in 2025 by Max Berthelot and Baptiste Debever.


Board


Investors · 9
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$20M disclosed across 1 of 3 rounds · 2025–2026
- $20MSeries AMay 2026 · 6 sources
Singular (lead), Céline Lazorthes, General Catalyst, investors behind Runna, Manu Lecomte, Y Combinator
Source ↗ - Undisclosed amountseed roundDec 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Aug 2026Lucis is a Paris-based preventive health company that pairs laboratory biomarker testing with an AI-driven health companion application. Members complete a health questionnaire covering goals, symptoms, history and lifestyle, optionally connect wearables, and are tested twice a year at partner laboratories, with blood, urine and saliva collected in a single visit. The panels cover more than 100 biomarkers on the first comprehensive assessment and 60+ on a six-month follow-up check, grouped into categories such as kidney health, inflammation, nutrients, metabolic, cardiac, liver health, minerals, adrenal function, thyroid hormones, bone health, sexual hormones, iron metabolism, hematology, immunity and prostate markers, and scored across 11 body systems.
Results are presented in a private dashboard with simplified wellness indices and plain-language explanations, alongside a personalized action plan produced by healthcare professionals spanning nutrition, supplementation, sleep, physical activity, environment and mental health. The AI companion combines biomarker results, longitudinal data and medical context, refreshing recommendations as new data arrives; outputs are reviewed by physicians. Lucis states that its content is educational and does not replace medical diagnosis, prescription or advice, and positions the structured data as a way for doctors to surface risks early and prepare appointments.
The company reports GDPR compliance, ISO 27001 certification for information security and HDS-certified hosting. Membership is open to people aged 18 and over.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 2
by search overlapCompanies competing with Lucis for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 3
launches, deals, and filingsLucis announced a $20 million Series A led by Singular with participation from General Catalyst, Y Combinator and angel investors, bringing total funding to $28M. Proceeds are earmarked for European expansion and development of its AI health companion app.
$20M source ↗
Lucis reported partnerships with laboratory groups including Eurofins and Randox to support sample collection and analysis.
Lucis stated it plans to launch in Spain, Germany and Italy by the end of 2026, adding to existing operations in France, the UK, Ireland and Portugal.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- Lucislucis.life · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Lucis do?
- European preventive health platform combining 110+ blood biomarker tests with an AI companion app and physician oversight.
- Who founded Lucis?
- Lucis was founded by Max Berthelot, Baptiste Debever in 2025.
- Who are Lucis's investors?
- Lucis's investors include Circle & Co., Clover, North South Ventures, Y Combinator, General Catalyst, Singular.
- How much funding has Lucis raised?
- Lucis has disclosed $20M raised across 1 of its 3 known rounds.
- Where is Lucis headquartered?
- Lucis is headquartered in Paris, FR.


.png)

